RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference

Ads

You May Also Like

MDxHealth Provides Business Update for the first nine months of 2018

NEWS RELEASE   REGULATED INFORMATION INTERIM TRADING UPDATE Product and Service revenue up 29% year-on-year IRVINE, ...

Trillium to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

TORONTO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical ...